Immunohistochemical detection of proteins associated with multidrug resistance to anti-cancer drugs in canine and feline primary pulmonary carcinoma

Journal of Veterinary Medical Science

Volumn 72, Issue 5, 2010, Pages 665-668

  Hifumi, Tatsuro ^a   Miyoshi, Noriaki ^a   Kawaguchi, Hiroaki ^b   Nomura, Kohji ^c   Yasuda, NObuhiro ^a  

^a Second Department of Pathology   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Marupi Lifetech Co Ltd   (Japan)

Author keywords

Immunohistochemistry; Lung resistance related protein; Metallothionein; Multidrug resistance related protein; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; TUMOR PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; DOG; DOG DISEASE; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; METHODOLOGY; MULTIDRUG RESISTANCE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM PROTEINS; P-GLYCOPROTEIN;

FELIDAE;

EID: 77953750709     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0519     Document Type: Article

References (23)

1. Clements, D.N., Hogan, A.M. and Cave, T.A. 2004. Treatment of a well differentiated pulmonary adenocarcinoma in a cat by pneumonectomy and adjuvant mitoxantrone chemotherapy. J. Feline Med. Surg. 6: 199-205.
2. Dincer, Z., Jasani, B., Haywood, S., Mullins, J.E. and Fuent-ealba, I.C. 2001. Metallothionein expression in canine and feline mammary and melanotic tumours. J. Comp. Pathol. 125: 130-136.
3. Dungworth, D.L., Hauser, B., Hahn, F.F., Wilson, D.W., Haen-ichen, T. and Harkema, J.R. 1999. Tumors of the Lung. pp. 2538. In: Histological Classification of Tumors of Respiratory System of Domestic Animals, 2nd Ser, The Armed Forces Institute of Pathology, Washington, D.C.
4. Dziegiel, P., Jeleri, M., Muszczyriska, B., Maciejczyk, A., Szulc, A., Podhorska-OkoIöw, M., Cegielski, M. and Zabel, M. 2004. Role of metallothionein expression in non-small cell lung carcinomas. Rocz. Akad. Med. Bialymst. 49: 43-45.
5. Fukushima, K., Okai, Y., Matsuura, S., Tsujimoto, H. and Endo, Y. 2006. Molecular cloning of feline lung resistance-related protein (LRP) cDNA and its expression in a feline lym-phoma cell line and adriamycin-resistant subline. J. Vet. Med. Sci. 68: 885-890.
6. German, U.A. 1996. P-glycoprotein- a mediator of multidrug resistance in tumor cells. Eur. J. Cancer 32: 927-944.
7. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K., Cole, S. P. and Deeley, R. G. 1994. Overexpression of mul-tidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54: 357-361.
8. Izquierdo, M.A., Scheffer, G.L., Flens, M.J., Shoemaker, R.H., Rome, L.H. and Scheper, R.J.1996. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology 19: 191-197.
9. Kelley, S.L., Basu, A., Teicher, B.A., Hacker, M.P., Hamer, H. and Lazo, J.S. 1988. Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815.
10. Kitazono, M., Sumizawa, T., Takebayashi, Y., Chen, Z.S., Furukawa, T., Nagayama, S., Tani, A., Takao, S., Aikou, T. and Akiyama, S. 1999. Multidrug resistance conferred by the lung resistance-related protein (LRP) on human colon carcinoma SW-620 cells. J. Natl. Cancer Inst. 91: 1647-1653.
11. Kobayashi, K., Shimada, A., Yamano, Y. and Umemura, T. 1997. Molecular cloning of a canine metallothionein cDNA. J. Vet. Med. Sci. 59: 819-823.
12. Kumar, V., Cotran,R.S. and Robbins,S.L. 2004. Lung tumors. pp. 624-631. In: Robbins Basic Pathology, 7th ed, Saunders, Philadelphia, Pennsylvania.
13. Laack, E., Bokemeyer, C. and Hossfeld, D.K. 2008. Adjuvant chemotherapy after complete resection of non-small cell lung cancer. Dtsch. Arztebl. Int. 105: 249-254.
14. Matsumoto, Y., Oka, M., Sakamoto, A., Narasaki, F., Fukuda, M., Takatani, H., Terashi, K., Ikeda, K., Tsurutani, J., Nagash-ima, S., Soda, H. and Kohno, S. 1997. Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapy. Anticancer Res. 17: 3777-3780.
15. Miyoshi, N., Tojo, E., Oishi, A., Fujiki, M., Misumi, K., Sakamoto, H., Kameyama, K., Shimizu, T. and Yasuda, N. 2002. Immunohistochemical detection of P-glycoprotein (PGP) and multidrug resistance-associated protein (MRP) in canine cutaneous mast cell tumors. J. Vet. Med. Sci. 64: 531-533.
16. Nooter, K. and Stoter, G. 1996. Molecular mechanisms of mul-tidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192: 768-780.
17. Paredes, L. A., Blanco, G.C., Echenique, E.M. and Lobo, C. 2007. Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer. Arch. Bronconeumol. 43: 479-484.
18. Richard, W. N. and Guillermo,C. C. 2005. Lung tumors. pp. 317-319. In: Small Animal Internal Medicine, 3rd ed, Mosby, Missouri.
19. Sato, T., Ito, J., Shibuya, H., Asano, K. and Watari, T. 2005. Pulmonary adenosquamous carcinoma in a dog. J. Vet. Med. A. Physiol. Pathol. Clin. Med. 52: 510-513.
20. Sauna, Z.E., Smith, M.M., Miiller, M., Kerr, K.M. and Ambud-kar, S.V. 2001. The mechanism of action of multidrug-resis-tance-linked P-glycoprotein. J. Bioenerg. Biomember. 33: 481-491.
21. Shimada, A., Yanagida, M. and Umemura, T. 1997. An immunohistochemical study on the tissue-specific localization of metallothionein in dogs. J. Comp. Pathol. 116: 1-11.
22. Sumizawa, T., Chuman, Y., Sakamoto, H., Iemura, K., Alm-quist, K. C., Deeley, R. G., Cole, S. P. and Akiyama, S. 1994. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharan-thine, and mezerein. Somat. Cell Mol. Genet. 20: 423-435.
23. Wilson, D. W. and Dungworth, D. L. 2002. Tumors of the respiratory tract. pp 365-399. In: Tumors in Domestic Animals, 4th ed. (Meuten, D. J. ed.), Iowa State Press, Iowa.